Michael Kahn > Akin > New York, United States > Lawyer Profile

Akin
ONE BRYANT PARK
NEW YORK, NY 10036
NEW YORK
United States
Michael Kahn photo

Work Department

Partner; Intellectual Property

Position

Michael Kahn’s practice focuses on patent infringement and trade secret litigation. He represents innovative companies in a broad range of sectors, including life sciences, medical devices, engineering, consumer products and communications. Michael carefully and efficiently evaluates and addresses patent infringement and trade secret claims in the context of his clients’ market position and business goals. His trial practice includes matters in district courts across the country and before the International Trade Commission (ITC). Michael is also called upon regularly for IP due diligence, both in transactional circumstances and in anticipation of litigation.

To learn more about Michael, please visit his profile here: https://www.akingump.com/en/lawyers-advisors/michael-p-kahn.html

Education

J.D., Fordham University School of Law, 2001
B.A., University of Pennsylvania, 1998

Lawyer Rankings

United States > Intellectual property > Patents: litigation (full coverage)

Akin’s patent litigation team are engaged in all major venues and demonstrates strength in the pharma and biotech industries. Its varied caseload includes Hatch-Waxman cases, IPR proceedings, and competitor disputes. Steven Maslowski, a life sciences patent specialist in Philadelphia, chairs the practice; Malowski’s notable roster of clients includes Johnson & Johnson and Boston Scientific. Also in Philadelphia, Matthew Pearson is a skilled litigator for life sciences patents, with a particular focus on biologics and antibody tech. Key attorneys in Washington DC include Cono Carrano, whose expertise spans semiconductors, computer and optics tech, and Rachel Elsby, who excels in business-critical life sciences cases. Meanwhile, Daniel Moffett, based in San Antonio, and Michael Kahn, based in New York, are experienced trial lawyers for patent infringement and misappropriated trade secret cases.